Ind Swift Laboratories Intrinsic Value

INDSWFTLAB • Healthcare
Current Stock Price
₹89.61
Primary Intrinsic Value
₹88.00
Market Cap
₹618.3 Cr
+38.0% Upside
Median Value
₹123.69
Value Range
₹27 - ₹224
Assessment
Trading Below Calculated Value
Safety Margin
27.6%

INDSWFTLAB Valuation Methods Summary

Method Type Intrinsic Value Range Upside/Downside Details
P/E Based Valuation earnings ₹88.00 ₹70.40 - ₹105.60 -1.8% EPS: ₹4.00, Sector P/E: 22x
Book Value Method asset ₹224.03 ₹201.63 - ₹246.43 +150.0% Book Value/Share: ₹170.00, P/B: 2.0x
Revenue Multiple Method revenue ₹179.22 ₹161.30 - ₹197.14 +100.0% Revenue/Share: ₹99.13, P/S: 2.0x
EBITDA Multiple Method earnings ₹108.11 ₹97.30 - ₹118.92 +20.6% EBITDA: ₹76.00Cr, EV/EBITDA: 10x
Simple DCF (5Y) dcf ₹224.03 ₹179.22 - ₹268.84 +150.0% CF Growth: 15.0%, Discount: 15%
PEG Ratio Method growth ₹26.88 ₹24.19 - ₹29.57 -70.0% EPS Growth: 8.0%, Fair P/E: 6.4x
Growth Adjusted P/E growth ₹61.80 ₹55.62 - ₹67.98 -31.0% Revenue Growth: 6.0%, Adj P/E: 15.5x
Graham Defensive Method conservative ₹123.69 ₹111.32 - ₹136.06 +38.0% EPS: ₹4.00, BVPS: ₹170.00
Method Types: Earnings Asset DCF Growth Dividend Conservative

Want to compare with current market value? Check INDSWFTLAB share price latest .

Valuation Comparison Chart

INDSWFTLAB Intrinsic Value Analysis

What is the intrinsic value of INDSWFTLAB?

Based on our comprehensive analysis using 8 different valuation methods, the estimated intrinsic value of Ind Swift Laboratories (INDSWFTLAB) is ₹123.69 (median value). With the current market price of ₹89.61, this represents a +38.0% variance from our estimated fair value.

The valuation range spans from ₹26.88 to ₹224.03, indicating ₹26.88 - ₹224.03.

Is INDSWFTLAB undervalued or overvalued?

Based on our multi-method analysis, Ind Swift Laboratories (INDSWFTLAB) appears to be trading below calculated value by approximately 38.0%.

Financial Health Analysis

Financial Metric Current Value Industry Benchmark Assessment Impact on Valuation
Current Ratio 19.22 Industry Standard: 2.0+ Above 2.0 Measures short-term liquidity capacity
Debt to Equity Ratio 1.23 Industry Standard: <0.5 Above 1.0 Indicates financial leverage level
Return on Equity 2.7% Industry Standard: 15%+ Below 10% Measures shareholder return efficiency
Operating Margin 1.0% Industry Standard: 20%+ Below 10% Indicates operational efficiency level
Asset Turnover Ratio 0.48x Industry Standard: 1.0x+ Below 0.5x Measures asset utilization efficiency

Cash Flow Quality Analysis

Period Operating Cash Flow Free Cash Flow Cash Flow Quality Sustainability Score
March 2025 ₹-26 Cr ₹-81 Cr Negative Cash Flow 3/10
March 2024 ₹-187 Cr ₹-201 Cr Negative Cash Flow 3/10
March 2023 ₹195 Cr ₹189 Cr Positive Free Cash Flow 8/10
March 2022 ₹150 Cr ₹150 Cr Positive Free Cash Flow 8/10
March 2021 ₹135 Cr ₹130 Cr Positive Free Cash Flow 8/10